Get the Stockscreener App
18.57
12.48%
2.06
After Hours:
19.49
0.92
+4.95%
Assertio Holdings Inc stock is traded at $18.57, with a volume of 301.06K.
It is up +12.48% in the last 24 hours and up +56.71% over the past month.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in comprehensive commercial capabilities, offering differentiated products designed to address patients' needs. Its focus is on supporting patients by marketing products mainly in the oncology market. The Company operates in the business within one reportable segment, relating to the sale of pharmaceutical products to its customers.
See More
Previous Close:
$16.51
Open:
$16.75
24h Volume:
301.06K
Relative Volume:
4.39
Market Cap:
$119.69M
Revenue:
$118.71M
Net Income/Loss:
$-30.38M
P/E Ratio:
-6.3088
EPS:
-2.9435
Net Cash Flow:
$-28.18M
1W Performance:
+35.75%
1M Performance:
+56.71%
6M Performance:
+33.82%
1Y Performance:
+61.22%
1-Day Range:
$16.62
$18.78
1-Week Range:
$12.68
$18.78
52-Week Range:
$7.7055
$18.78
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
18.57 | 106.41M | 118.71M | -30.38M | -28.18M | -2.9435 |
TAK
Takeda Pharmaceutical Co Adr
|
18.29 | 56.99B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
116.71 | 48.94B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.74 | 43.30B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.46 | 33.94B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
541.60 | 23.31B | 3.18B | 1.33B | 1.04B | 27.90 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-26-24 | Initiated | Maxim Group | Buy |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| Nov-07-22 | Initiated | Lake Street | Buy |
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
Assertio (ASRT) Surges 17.9%: Is This an Indication of Further Gains? - Yahoo Finance Australia
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Research Analysts Set Expectations for Assertio Q1 Earnings - MarketBeat
Assertio outlines $110M–$125M 2026 revenue target with Rolvedon at the core while shifting business development approach - MSN
Assertio (NASDAQ:ASRT) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
H.C. Wainwright reiterates Assertio stock rating on strong revenue - Investing.com UK
H.C. Wainwright reiterates Assertio stock rating on strong revenue By Investing.com - Investing.com South Africa
Assertio Holdings, Inc. (NASDAQ:ASRT) Q4 2025 Earnings Call Transcript - Insider Monkey
Assertio Holdings 2025 Annual Report: Business Overview, Strategy, Risks, and Financial Performance - Minichart
Assertio Holdings Inc (ASRT) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Assertio Holdings, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Assertio Q4 2025 misses EPS forecast By Investing.com - Investing.com India
Assertio Holdings 2025 Results & New Strategy: Rolvedon Focus, End of Acquisition-Led GrowthNews and Statistics - IndexBox
Earnings Call Summary | Assertio(ASRT.US) Q4 2025 Earnings Conference - 富途牛牛
Earnings call transcript: Assertio Q4 2025 misses EPS forecast - Investing.com
Assertio Q4 Earnings Call Highlights - MarketBeat
Assertio (ASRT) Q4 2025 Earnings Call Transcript - The Globe and Mail
Assertio (ASRT) Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget
Assertio Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Assertio (ASRT) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Assertio Holdings 2025 10-K: Revenues $118.7M, EPS loss $(4.74) - TradingView
Assertio Holdings Q4 2025 Results: $11.9M Loss, Revenue $13.5MNews and Statistics - IndexBox
Assertio Q4 Swings to Adjusted Loss, Revenue Declines - marketscreener.com
Assertio (NASDAQ: ASRT) 2025 report centers on ROLVEDON, divestiture and reverse split - Stock Titan
Assertio: Q4 Earnings Snapshot - kens5.com
Assertio (NASDAQ:ASRT) Posts Quarterly Earnings Results, Beats Estimates By $1.19 EPS - MarketBeat
Assertio (NASDAQ: ASRT) 2025 results and 2026 earnings guidance - Stock Titan
Assertio Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Assertio Reports Fourth Quarter and Full Year 2025 Financial Results - marketscreener.com
BRIEF-Assertio Holdings, Inc. Q4 Adjusted EPS USD -1.06 Vs. IBES Estimate USD -2.71 - TradingView
Assertio Holdings, Inc. Provides Earnings Guidance for the Full Year 2026 - marketscreener.com
ASRT Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Assertio Holdings Q4 2025 earnings preview - MSN
Assertio Holdings Inc expected to post a loss of $2.71 a shareEarnings Preview - TradingView
ASRT Stock Price, Quote & Chart | ASSERTIO HOLDINGS INC (NASDAQ:ASRT) - ChartMill
Assertio regains Nasdaq compliance after bid price recovery - MSN
How Assertio Holdings (ASRT) Narrative Is Shifting Around A Steady 37.44 Fair Value Target - Yahoo Finance
Does Assertio Holdings Inc have declining or rising EPSMarket Movement Recap & Daily Entry Point Trade Alerts - baoquankhu1.vn
AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know - Finviz
Assertio Holdings to Release 2025 Financial Results on March 16, 2026 - geneonline.com
Assertio Holdings Inc (ASRT) News, Articles, Events & Latest Updates - Stocktwits
Is Assertio (ASRT) Outperforming Other Medical Stocks This Year? - Yahoo Finance
ASRT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Assertio (ASRT) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Assertio Holdings to Report Q4 and Full Year 2025 Earnings - National Today
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2 - PharmiWeb.com
Assertio Holdings (ASRT) grants CFO RSUs and 21,128 stock options - Stock Titan
Assertio (ASRT) President and COO receives new RSUs and stock options grant - Stock Titan
Assertio (ASRT) EVP awarded new RSUs and stock options - Stock Titan
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 - marketscreener.com
ASRT Technical Analysis & ETF Price Forecast - Intellectia AI
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.12%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):